BACR home page

Welcome to the British Association for Cancer Research

The BACR is the largest British-based cancer society with a membership of almost 1,200.
It was formed in 1960 to promote the advance of research in relation to all aspects of cancer, both laboratory and clinical, and to encourage the exchange of information.
It achieves this aim by educational and training opportunities for all those involved in the cancer field, particularly the next generation of cancer research professionals.

BACR 50th Anniversary Celebration meeting 'Hallmarks of Cancer: from Mechanisms to Therapies'

Edinburgh 2010

Ten years ago Hanahan and Weinberg published a key paper (Cell, 100, 57-70) describing how after a quarter century of rapid advances, cancer research had revealed cancer to be a disease involving dynamic changes in the genome. They described six essential alterations in cell physiology that collectively dictate malignant growth, which they termed the Hallmarks of Cancer. In the BACR 50th Anniversary Meeting we have invited international leaders in cancer research to revisit the Hallmarks of Cancer and to discuss their views on how this has impacted on translation of mechanisms to novel therapies and future approaches which will improve the survival of cancer patients.
Please register here.
Sponsorship and Trade Exhibition

Fellowships and bursaries

The awarding of Fellowships and Bursaries is one of the major activities of the Association as part of its remit to provide educational and training opportunities for all those involved in the cancer field.
In particular the Travel/Exchange Fellowship scheme provides an excellent opportunity for researchers in the UK to spend time learning new techniques and gaining experience in another laboratory. More information

BACR/RSM Oncology Section Special Conference “Predictive biomarkers of response to cancer therapeutics”

Thursday 25th March 2010
Royal Society of Medicine, London, UK

With the emergence in recent years of several novel molecules with putative efficacy in cancer management, the search for biomarkers of response which can potentially be used in their clinical evaluation is extremely topical. The objective of this conference is to provide a state-of-the-art overview of biomarkers in cancer chemotherapy and chemoprevention. It is aimed at researchers (basic scientists and clinicians) engaged in translational cancer pharmacology and new anticancer drug development in academia, industry and hospitals.

Register on line here.